115 related articles for article (PubMed ID: 2349266)
21. Behavioral responses to apomorphine and amphetamine in differentially housed mice.
Wilmot CA; Vander Wende C; Spoerlein MT
Psychopharmacology (Berl); 1984; 84(1):105-8. PubMed ID: 6436876
[TBL] [Abstract][Full Text] [Related]
22. Behavioral effects of amphetamine and apomorphine after striatal lesions in the rat.
Antoniou K; Kafetzopoulos E
Pharmacol Biochem Behav; 1992 Nov; 43(3):705-22. PubMed ID: 1448467
[TBL] [Abstract][Full Text] [Related]
23. Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats.
Geyer MA; Russo PV; Segal DS; Kuczenski R
Pharmacol Biochem Behav; 1987 Nov; 28(3):393-9. PubMed ID: 3685075
[TBL] [Abstract][Full Text] [Related]
24. NMDA antagonists block expression of sensitization of amphetamine- and apomorphine-induced stereotypy.
Battisti JJ; Shreffler CB; Uretsky NJ; Wallace LJ
Pharmacol Biochem Behav; 2000 Oct; 67(2):241-6. PubMed ID: 11124387
[TBL] [Abstract][Full Text] [Related]
25. Mixed D2/5-HT2 antagonism differentially affects apomorphine- and amphetamine-induced stereotyped behavior.
Feldman DJ; Frank RA; Kehne JH; Flannery R; Brown D; Soni S; Byrd G; Shah S
Pharmacol Biochem Behav; 1997 Oct; 58(2):565-72. PubMed ID: 9300620
[TBL] [Abstract][Full Text] [Related]
26. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats.
Castellani S; Adams PM
Eur J Pharmacol; 1981 Jul; 73(2-3):143-54. PubMed ID: 7198045
[TBL] [Abstract][Full Text] [Related]
27. The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats.
Kleinrok Z; Turski L; Wawrzyniak M; Cybulska R
Pol J Pharmacol Pharm; 1981; 33(2):149-59. PubMed ID: 7198226
[TBL] [Abstract][Full Text] [Related]
28. Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenethylamine and apomorphine.
Mogilnicka E; Braestrup C
J Pharm Pharmacol; 1976 Mar; 28(3):253-5. PubMed ID: 6705
[No Abstract] [Full Text] [Related]
29. [Effect of N-(4-picolyl)-3,5 dimethylbenzamide (M-14012-4) on stereotyped behavior induced by apomorphine and amphetamine in the rat and mouse].
Casais PL; Chermat R; Cuenca E; Simón P
Arch Farmacol Toxicol; 1981 Apr; 7(1):65-72. PubMed ID: 7198897
[No Abstract] [Full Text] [Related]
30. The effects of cysteamine on dopamine-mediated behaviors: evidence for dopamine-somatostatin interactions in the striatum.
Martin-Iverson MT; Radke JM; Vincent SR
Pharmacol Biochem Behav; 1986 Jun; 24(6):1707-14. PubMed ID: 2874568
[TBL] [Abstract][Full Text] [Related]
31. Neuropeptide-dopamine interactions. II. Cyclo (His-Pro) augmentation of amphetamine- but not apomorphine-induced stereotypic behavior.
Prasad C
Behav Brain Res; 1988 Mar; 27(3):241-5. PubMed ID: 3358861
[TBL] [Abstract][Full Text] [Related]
32. Influence of the estrous cycle and estradiol on the behavioral effects of amphetamine and apomorphine in rats.
Díaz-Véliz G; Baeza R; Benavente F; Dussaubat N; Mora S
Pharmacol Biochem Behav; 1994 Dec; 49(4):819-25. PubMed ID: 7886093
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of the behavioral effects of d-amphetamine and apomorphine in the rat.
Antoniou K; Kafetzopoulos E
Pharmacol Biochem Behav; 1991 May; 39(1):61-70. PubMed ID: 1924514
[TBL] [Abstract][Full Text] [Related]
34. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
Spyraki C; Fibiger HC
Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991
[TBL] [Abstract][Full Text] [Related]
35. [The characterization of central neuromediation in rats fed with magnesium-deprived diet before and after magnesium replenishment].
Spasov AA; Iezhitsa IN; Kravchenko MS; Kharitonova MV
Ross Fiziol Zh Im I M Sechenova; 2008 Jul; 94(7):822-33. PubMed ID: 18767395
[TBL] [Abstract][Full Text] [Related]
36. Apomorphine effects on behavioral response to ethanol in mice selectively bred for differential sensitivity to ethanol.
Dudek BC; Abbott ME; Garg A; Phillips TJ
Pharmacol Biochem Behav; 1984 Jan; 20(1):91-4. PubMed ID: 6538046
[TBL] [Abstract][Full Text] [Related]
37. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
Castall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
[TBL] [Abstract][Full Text] [Related]
38. Psychotomimetics potentiate locomotor hyperactivity induced by dopaminergic drugs.
Fink H; Morgenstern R; Oelssner W
Pharmacol Biochem Behav; 1979 Nov; 11(5):479-82. PubMed ID: 531070
[TBL] [Abstract][Full Text] [Related]
39. Analysis of aggressiveness-stereotype complex induced in mice by amphetamine or nialamide and L-dopa.
Roliński Z
Pol J Pharmacol Pharm; 1973; 25(6):551-8. PubMed ID: 4799834
[No Abstract] [Full Text] [Related]
40. A neuropharmacological analysis of central nervous system catecholamine systems in development protein malnutrition.
Leahy JP; Stern WC; Resnick O; Morgane PJ
Dev Psychobiol; 1978 Jul; 11(4):361-70. PubMed ID: 566687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
